Unusual Large Call Buy in Potential Breast Cancer Winner into Q4 Readout Nov 18, 2021 Olema Oncology (OLMA) jumps here with an unusual buy of 3100 December $30 calls for $4. OLMA is a $1B Biotech discovering therapies for women’s... read more
